The Novo-backed surgical implant provider floated at the top of its range and increased the number of shares in the offering.
SI-Bone, a US-based surgical implant producer backed by pharmaceutical firm Novo, went public on Wednesday in a $108m initial public offering, issuing 7.2 million shares at $15.00 each.
The IPO price represented the top of the $13 to $15 range SI-Bone had set, and it increased the number of shares in the offering from 6.9 million. Its shares opened at $20.15 on its first day of trading on the Nasdaq Global Market and closed at $21.00 yesterday.
SI-Bone is…
